1. Powell JJ, Wojnarowska F: Lichen sclerosus. Lancet 353:1777, 1999
2. Marini A et al: Lichen sclerosus: New aspects of pathogenesis and treatment. Hautarzt 56:550, 2005
3. Powell JJ, Wojnarowska F: Childhood vulvar lichen sclerosus: An increasingly common problem. J Am Acad Dermatol 44:803, 2001
4. Kizer WS, Prarie T, Morey AF: Balanitis xerotica obliterans: Epidemiologic distribution in an equal access health care system. South Med 96:9, 2003
5. Aynaud O, Piron D, Casanova JM: Incidence of preputial lichen sclerosus in adults: Histologic study of circumcision specimens. J Am Acad Dermatol 41:923, 1999
6. Tokgoz H et al: Histopathological evaluation of the preputium in preschool and primary school boys. Int Urol Nephrol 36:573, 2004
7. Meyrick Thomas RH et al: Lichen sclerosus et atrophicus and autoimmunity—A study of 350 women. Br J Dermatol 118:41, 1988
8. Sherman V et al: The high rate of familial lichen sclerosus suggests a genetic contribution: An observational cohort study. J Eur Acad Dermatol Venereol 24:1031, 2010
9. Oyama N et al: Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 362:118, 2003
10. Howard A et al: Circulating basement membrane zone antibodies are found in lichen sclerosus of the vulva. Australas J Dermatol 45:12, 2004
11. Chan I: The role of extracellular matrix protein 1 in human skin. Clin Exp Dermatol 29:52, 2004
12. Kowalewski C et al: Three-dimensional imaging reveals major changes in skin microvasculature in lipoid proteinosis and lichen sclerosus. J Dermatol Sci 38:215, 2005
13. Baldo M et al: Childhood vulval lichen sclerosus: Autoimmunity to the basement membrane zone protein BP180 and its relationship to autoimmunity. Clin Exp Dermatol 35:543, 2010
14. Carli P et al: Fibrogenic cytokines in vulvar lichen sclerosus. An immunohistochemical study. J Reprod Med 42:161, 1997
15. Scrimin F et al: Vulvar lichen sclerosus: An immunologic study. Obstet Gynecol 95:147, 2000
16. Attili VR, Attili SK: Lichen sclerosus of lips: A clinical and histopathologic study of 27 cases. Int J Dermatol 49:520, 2010
17. Fung MA, LeBoit PE: Light microscopic criteria for the diagnosis of early vulvar lichen sclerosus: A comparison with lichen planus. Am J Surg Pathol 22:473, 1998
18. Farrell AM et al: Lichen sclerosus: Evidence that immunological changes occur at all levels of the skin. Br J Dermatol 140:1087, 1999
19. Carlson JA et al: Comparative immunophenotypic study of lichen sclerosus: Epidermotropic CD57+ lymphocytes are numerous—Implications for pathogenesis. Am J Dermatopathol 22:7, 2000
20. Regauer S, Reich O, Beham-Schmid C: Monoclonal gamma-T-cell receptor rearrangement in vulvar lichen sclerosus and squamous cell carcinomas. Am J Pathol 160:1035, 2002
21. Oyama N et al: Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. J Clin Invest 113:1550, 2004
22. Foldes-Papp Z et al: Lack of specific immunological disease pattern in vulvar lichen sclerosus. Exp Mol Pathol 79:176, 2005
23. De Vito JR et al: Role of Borrelia burgdorferi in the pathogenesis of morphea/scleroderma and lichen sclerosus et atrophicus: A PCR study of thirty-five cases. J Cutan Pathol 23:350, 1996
24. Khachemoune A, Guldbakke KK, Ehrsam E: Infantile perineal protrusion. J Am Acad Dermatol 54:1046, 2006
25. Maronn ML, Esterly NB: Constipation as a feature of anogenital lichen sclerosus in children. Pediatrics 115:e230, 2005
26. Isaac R, Lyn M, Triggs N: Lichen sclerosus in the differential diagnosis of suspected child abuse cases. Pediatr Emerg Care 23:482, 2007
27. Khachemoune A, Guldbakke KK, Ehrsam E: Infantile perineal protrusion. J Am Acad Dermatol 54:1046, 2006
28. Powell J, Wojnarowska F: Childhood vulval lichen sclerosus and sexual abuse are not mutually exclusive diagnoses. BMJ 320:311, 2000
29. Hagedorn M et al: Survey of genital lichen sclerosus in women and men. Arch Gynecol Obstet 266:86, 2002
30. von Krogh G, Dahlman-Ghozlan K, Syrjanen S: Potential human papilloma-virus reactivation following topical corticosteroid therapy of genital lichen sclerosus and erosive lichen planus. J Eur Acad Dermatol Venereol 16:130, 2002
31. Jones RW et al: Clinically identifying women with vulvar lichen sclerosus at increased risk of squamous cell carcinoma: A case-control study. J Reprod Med 49:808, 2004
32. Cooper SM et al: Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol 140:702, 2004
33. Smith SD, Fischer G: Childhood onset vulvar lichen sclerosus does not resolve at puberty: A prospective case series. Pediatr Dermatol 26:725-729, 2009
34. Patrizi A et al: Childhood lichen sclerosus: A long-term follow-up. Pediatr Dermatol 27:101, 2010
35. Dalziel KL, Millard PR, Wojnarowska F: The treatment of vulval lichen sclerosus with a very potent topical steroid (
clobetasol propionate 0.05%) cream.
Br J Dermatol 124:461, 1991
36. Fischer G, Rogers M: Treatment of childhood vulvar lichen sclerosus with potent topical corticosteroid. Pediatr Dermatol 14:235, 1997
37. Bornstein J et al:
Clobetasol dipropionate 0.05% versus
testosterone propionate 2% topical application for severe vulvar lichen sclerosus.
Am J Obstet Gynecol 178:80, 1998
38. Lorenz B, Kaufman RH, Kutzner SK: Lichen sclerosus. Therapy with
clobetasol propionate.
J Reprod Med 43:790, 1998
39. Dahlman-Ghozlan K, Hedblad MA, von Krogh G: Penile lichen sclerosus et atrophicus treated with
clobetasol dipropionate 0.05% cream: A retrospective clinical and histopathological study.
J Am Acad Dermatol 40:451, 1999
40. Garzon MC, Paller AS: Ultrapotent topical corticosteroid treatment of childhood genital lichen sclerosus. Arch Dermatol 135:525, 1999
41. Neill SM, Ridley CM: Management of anogenital lichen sclerosus. Clin Exp Dermatol 26:637, 2001
42. Cattaneo A et al: Topical
mometasone furoate for vulvar lichen sclerosus.
J Reprod Med 48:444, 2003
43. Renaud-Vilmer C et al: Vulvar lichen sclerosus: Effect of long-term topical application of a potent steroid on the course of the disease. Arch Dermatol 140:709, 2004
44. Assmann T et al:
Tacrolimus ointment for the treatment of vulvar lichen sclerosus.
J Am Acad Dermatol 48:935, 2003
45. Bohm M et al: Successful treatment of anogenital lichen sclerosus with topical
tacrolimus.
Arch Dermatol 139:922, 2003
46. Kunstfeld R et al: Successful treatment of vulvar lichen sclerosus with topical
tacrolimus.
Arch Dermatol 139:850, 2003
47. Boms S et al:
Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood.
BMC Dermatol 4:14, 2004
48. Goldstein AT, Marinoff SC, Christopher K:
Pimecrolimus for the treatment of vulvar lichen sclerosus: A report of 4 cases.
J Reprod Med 49:778, 2004
49. Hengge UR, Ruzicka T, Cork M: Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 54:1, 2006
50. Hengge UR et al: Multicenter, phase-II trial on the safety and efficacy of topical
tacrolimus ointment for the treatment of lichen sclerosus.
Br J Dermatol 155:1021, 2006
51. Stucker M et al: The outcome after cryosurgery and intralesional steroid injection in vulvar lichen sclerosus corresponds to preoperative histopathological findings. Dermatology 210:218, 2005
52. Reichrath J, Reinhold U, Tilgen W: Treatment of genito-anal lesions in inflammatory skin diseases with PUVA cream photochemotherapy: An open pilot study in 12 patients. Dermatology 205:245, 2002
53. Kreuter A et al: Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: Results of a preliminary study. J Am Acad Dermatol 46:251, 2002
54. Beattie PE et al: UVA1 phototherapy for genital lichen sclerosus. Clin Exp Dermatol 31:343, 2006